YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2

YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2

N6-methyladenosine (m6A) is the most common post-transcriptional modification of RNA in eukaryotes, which has been demonstrated to play important roles in various cancers. YTHDF1 acts as a crucial m6A “reader” and regulates the fate of m6A modified mRNA. However, its role in cervical cancer remains...

Full description

Bibliographic Details
Main Authors:	Haocheng Wang, Qingya Luo, Jianyi Kang, Qinglv Wei, Yu Yang, Dan Yang, Xiaoyi Liu, Tao Liu, Ping Yi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Oncology
Subjects:	cervical cancer N6-methyladenosine YTHDF1 tumorigenicity RANBP2
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.650383/full

Similar Items

YTHDF1 in Tumor Cell Metabolism: An Updated Review
by: Haichuan Rong, et al.
Published: (2023-12-01)

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
by: Xiangxiang Liu, et al.
Published: (2020-12-01)

Profiling of N6-methyladenosine methylation in porcine longissimus dorsi muscle and unravelling the hub gene ADIPOQ promotes adipogenesis in an m6A-YTHDF1–dependent manner
by: Huanfa Gong, et al.
Published: (2023-04-01)

Expression and Clinical Significance of the m6A RNA-Binding Proteins YTHDF2 in Peripheral Blood Mononuclear Cells From New-Onset Ankylosing Spondylitis
by: Qing Luo, et al.
Published: (2022-06-01)

The mechanism underlying redundant functions of the YTHDF proteins
by: Zhongyu Zou, et al.
Published: (2023-01-01)

RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68
by: Qihong Nie, et al.
Published: (2023-12-01)

YTHDF1 mitigates acute kidney injury via safeguarding m6A-methylated mRNAs in stress granules of renal tubules
by: Wenwen Yang, et al.
Published: (2023-11-01)

Clinical implications of m6A‐related regulators YTHDF1 and YTHDF2 in hepatocellular carcinoma
by: Nanfang Qu, et al.
Published: (2022-12-01)

RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression
by: Zheng Zhang, et al.
Published: (2024-01-01)

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
by: Ganglin Su, et al.
Published: (2021-08-01)

Ythdf2-mediated m6A mRNA clearance modulates neural development in mice
by: Miaomiao Li, et al.
Published: (2018-05-01)

The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner
by: Xiao-Yu Chen, et al.
Published: (2021-03-01)

Research Progress on Relation Between YTHDF1 and Tumors
by: XIAO Shiwei, et al.
Published: (2020-09-01)

The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases
by: Zuyao Chen, et al.
Published: (2021-12-01)

YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway
by: Teng Zhao, et al.
Published: (2022-02-01)

N6‐methyladenosine reader YTHDF3 regulates melanoma metastasis via its ‘executor' LOXL3
by: Hao‐ze Shi, et al.
Published: (2022-11-01)

The m6A Readers YTHDF1 and YTHDF2 Synergistically Control Cerebellar Parallel Fiber Growth by Regulating Local Translation of the Key Wnt5a Signaling Components in Axons
by: Jun Yu, et al.
Published: (2021-11-01)

YTHDF2 Regulates Maternal Transcriptome Degradation and Embryo Development in Goat
by: Mingtian Deng, et al.
Published: (2020-09-01)

The m<sup>6</sup>A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m<sup>6</sup>A-Dependent Manner
by: Hongtao Diao, et al.
Published: (2023-01-01)

Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner
by: Yangyang Chen, et al.
Published: (2023-02-01)

YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
by: Kazuo Tsuchiya, et al.
Published: (2021-01-01)

RANBP2 susceptibility to infection-induced encephalopathy: Clinicoradiologic and molecular description in a Malaysian family
by: H.B. Chew, et al.
Published: (2020-09-01)

RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma
by: Yeon-Jee Kahm, et al.
Published: (2023-04-01)

N<sup>6</sup>-Methyladenosine RNA-Binding Protein YTHDF1 in Gastrointestinal Cancers: Function, Molecular Mechanism and Clinical Implication
by: Danyu Chen, et al.
Published: (2022-07-01)

N6‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma
by: Gaochao Dong, et al.
Published: (2023-10-01)

GMEB2 Promotes the Growth of Colorectal Cancer by Activating ADRM1 Transcription and NF-κB Signalling and Is Positively Regulated by the m<sup>6</sup>A Reader YTHDF1
by: Zhengping Ning, et al.
Published: (2022-12-01)

RNA N6-methyladenosine modification mediates downregulation of NR4A1 to facilitate malignancy of cervical cancer
by: Tao Yu, et al.
Published: (2022-12-01)

m6A binding protein YTHDF2 in cancer
by: Xiaomin Chen, et al.
Published: (2022-04-01)

N6-Methyladenosine and Reader Protein YTHDF2 Enhance the Innate Immune Response by Mediating DUSP1 mRNA Degradation and Activating Mitogen-Activated Protein Kinases during Bacterial and Viral Infections
by: Jian Feng, et al.
Published: (2023-02-01)

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
by: Lin Chen, et al.
Published: (2023-03-01)

RANBP1 (RAN Binding Protein 1): The Missing Genetic Piece in Cancer Pathophysiology and Other Complex Diseases
by: Salvatore Audia, et al.
Published: (2023-01-01)

N6-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression
by: Nagaraja Tirumuru, et al.
Published: (2016-07-01)

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma
by: Young Wha Koh, et al.
Published: (2022-11-01)

COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement
by: Thanakit Pongpitakmetha, et al.
Published: (2022-07-01)

Aurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2
by: Erica Di Cesare, et al.
Published: (2023-01-01)

Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals
by: Yuling Li, et al.
Published: (2019-04-01)

RNA N6‐methyladenosine connects YTHDF3 and LOXL3 to promote melanoma metastasis
by: Mamta B Nirmal, et al.
Published: (2022-12-01)

Workshop on RanBP2/Nup358 and acute necrotizing encephalopathy
by: Alexander F. Palazzo, et al.
Published: (2022-12-01)

YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
by: Jiajie Hou, et al.
Published: (2019-11-01)

PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt–β-catenin pathway
by: Peng Yu, et al.
Published: (2024-04-01)